fda approves first oral glp-1 obesity drug august 1 2025 The approved a pill version of the receptor agonist semaglutide (Wegovy), making it the GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 The FDA has approved the
Pay in 4 interest-free payments of $6.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25


:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)



























